Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19915222 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
Conditions: Atherosclerosis;   Acute Coronary Syndrome (ACS)
Interventions: Drug: Cangrelor;   Drug: clopidogrel;   Drug: Placebo bolus & placebo infusion;   Drug: Placebo capsules - end of PCI;   Drug: Placebo capsules - end of infusion

Indicates status has not been verified in more than two years